UB
Upstream Biotechnology, Inc.
SEC filingOther Technology · Durham, NC
Amount raised$625Ksold at filing
Total offering$1.6M$1M still open
Investors in the raise3count reported to the SEC
FiledSep 17, 2025first sale Aug 26, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Karen H. LeVertDirector
Xiao-fang H. WangDirector
George H. GreeneExecutive Officer, Director
Xinnian H. DongDirector
Executive officers, directors and promoters as listed on the Form D.